This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Jennifer Hanisak: Innovator in IRAK4 Inhibition
Introduction
Jennifer Hanisak is a prominent inventor based in Stewartsville, NJ (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors targeting IRAK4 activity. Her work is crucial for advancing treatments for various IRAK4-mediated conditions.
Latest Patents
Jennifer holds a patent for "Inhibitors of IRAK4 activity." This invention relates to inhibitors of IRAK4 of Formula (I) and provides compositions comprising such inhibitors. Additionally, it outlines methods for treating IRAK4-mediated or -associated conditions or diseases. This patent showcases her innovative approach to addressing critical health issues.
Career Highlights
Jennifer is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create effective therapeutic solutions.
Collaborations
Some of her notable coworkers include W Michael Seganish and Guoqing Li. Their collaborative efforts contribute to the advancement of research and innovation within their field.
Conclusion
Jennifer Hanisak is a dedicated inventor whose work in IRAK4 inhibition is paving the way for new treatment options. Her contributions to Merck Sharp & Dohme Corporation and the pharmaceutical industry are commendable and impactful.